CDK6 and colorectal carcinoma: Intriguingly, since CBP1 could propagate without overexpression of CDK6 and activated KRAS, it suggests that CDK14 (PFTK1) could play an important, independent role in the growth of CRC tumors outside the GI tract and metastasis.